guanidine has been researched along with Local Neoplasm Recurrence in 1 studies
Guanidine: A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.
guanidine : An aminocarboxamidine, the parent compound of the guanidines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Meta-iodobenzylguanidine(MIBG) scans are used to detect neuroblastoma metastatic lesions at diagnosis and during posttreatment surveillance." | 8.02 | Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome. ( Deyell, RJ; Farfan, M; Irwin, MS; Moorehead, PC; Morgenstern, DA; Portwine, C; Rafael, MS; Shammas, A; Usmani, N; Vali, R; Vanniyasingam, T, 2021) |
| "Meta-iodobenzylguanidine(MIBG) scans are used to detect neuroblastoma metastatic lesions at diagnosis and during posttreatment surveillance." | 4.02 | Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome. ( Deyell, RJ; Farfan, M; Irwin, MS; Moorehead, PC; Morgenstern, DA; Portwine, C; Rafael, MS; Shammas, A; Usmani, N; Vali, R; Vanniyasingam, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Usmani, N | 1 |
| Deyell, RJ | 1 |
| Portwine, C | 1 |
| Rafael, MS | 1 |
| Moorehead, PC | 1 |
| Shammas, A | 1 |
| Vali, R | 1 |
| Farfan, M | 1 |
| Vanniyasingam, T | 1 |
| Morgenstern, DA | 1 |
| Irwin, MS | 1 |
1 other study available for guanidine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome.
Topics: 3-Iodobenzylguanidine; Guanidine; Humans; N-Myc Proto-Oncogene Protein; Neoplasm Recurrence, Local; | 2021 |